Download PDF
Semin Reprod Med 2024; 42(01): 005-014
DOI: 10.1055/s-0044-1787687
Review Article

Role of Anti-Müllerian Hormone in Male Reproduction and Sperm Motility

Hamza Benderradji
1   Department of Endocrinology, Diabetology, and Metabolism, CHU Lille, Lille, France
2   Inserm, CHU Lille, Unit 1172, Lille Neuroscience & Cognition (LilNCog), University of Lille, Lille, France
3   Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille University Hospital, Lille, France
,
Julie Prasivoravong
3   Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille University Hospital, Lille, France
,
François Marcelli
3   Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille University Hospital, Lille, France
,
Clara Leroy
3   Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille University Hospital, Lille, France
4   Department of Pediatric Endocrinology, Reference Centre for Genital Development Abnormalities, University of Lille, CHU Lille, DevGen, Lille, France
› Author Affiliations Funding This review did not receive any specific grants from any funding agency in the public, commercial, or nonprofit sectors.
› Further Information
   Permissions and Reprints

Abstract

Anti-Müllerian hormone (AMH) is secreted by Sertoli cells and is responsible for the regression of Müllerian ducts in the male fetus as part of the sexual differentiation process. Serum AMH concentrations are at their lowest levels in the first days after birth but increase after the first week, likely reflecting active Sertoli cell proliferation. AMH rises rapidly in concentration in boys during the first month, reaching a peak level at ∼6 months of age, and it remains high during childhood, then they will slowly decline during puberty, falling to low levels in adulthood. Serum AMH measurement is used by pediatric endocrinologist as a specific marker of immature Sertoli cell number and function during childhood. After puberty, AMH is released especially by the apical pole of the Sertoli cells toward the lumen of the seminiferous tubules, resulting in higher levels in the seminal plasma than in the serum. Recently, AMH has received increasing attention in research on male fertility–related disorders. This article reviews and summarizes the potential contribution of serum AMH measurement in different male fertility–related disorders.

Keywords

anti-Müllerian hormone - male infertility - sperm motility

Authors' Contributions

I confirm that all authors participated in writing the manuscript and have seen and approved the submitted version.




Publication History

Article published online:
24 June 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Benderradji H, Barbotin AL, Leroy-Billiard M. et al. Defining reference ranges for serum anti-Müllerian hormone on a large cohort of normozoospermic adult men highlights new potential physiological functions of AMH on FSH secretion and sperm motility. J Clin Endocrinol Metab 2022; 107 (07) 1878-1887
    CrossrefPubMedGoogle Scholar
  • 2 Aksglaede L, Sørensen K, Boas M. et al. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010; 95 (12) 5357-5364
    CrossrefPubMedGoogle Scholar
  • 3 di Clemente N, Wilson C, Faure E. et al. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 1994; 8 (08) 1006-1020
    PubMedGoogle Scholar
  • 4 Cate RL, Mattaliano RJ, Hession C. et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986; 45 (05) 685-698
    CrossrefPubMedGoogle Scholar
  • 5 Barbotin AL, Peigné M, Malone SA, Giacobini P. Emerging roles of anti-Müllerian hormone in hypothalamic-pituitary function. Neuroendocrinology 2019; 109 (03) 218-229
    CrossrefPubMedGoogle Scholar
  • 6 Cohen-Haguenauer O, Picard JY, Mattéi MG. et al. Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987; 44 (01) 2-6
    CrossrefPubMedGoogle Scholar
  • 7 Baarends WM, Uilenbroek JT, Kramer P. et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995; 136 (11) 4951-4962
    CrossrefPubMedGoogle Scholar
  • 8 Mishina Y, Rey R, Finegold MJ. et al. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996; 10 (20) 2577-2587
    CrossrefPubMedGoogle Scholar
  • 9 Shi Y, Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003; 113 (06) 685-700
    CrossrefPubMedGoogle Scholar
  • 10 Josso N, Clemente Nd. Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-β family. Trends Endocrinol Metab 2003; 14 (02) 91-97
    CrossrefPubMedGoogle Scholar
  • 11 Moses MM, Behringer RR. A gene regulatory network for Müllerian duct regression. Environ Epigenet 2019; 5 (03) dvz017
    CrossrefPubMedGoogle Scholar
  • 12 Rey R, Lukas-Croisier C, Lasala C, Bedecarrás P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003; 211 (1-2): 21-31
    CrossrefPubMedGoogle Scholar
  • 13 Rey RA, Grinspon RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab 2011; 25 (02) 221-238
    CrossrefPubMedGoogle Scholar
  • 14 Renault CH, Aksglaede L, Wøjdemann D, Hansen AB, Jensen RB, Juul A. Minipuberty of human infancy - a window of opportunity to evaluate hypogonadism and differences of sex development?. Ann Pediatr Endocrinol Metab 2020; 25 (02) 84-91
    CrossrefPubMedGoogle Scholar
  • 15 Bergadá I, Milani C, Bedecarrás P. et al. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006; 91 (10) 4092-4098
    CrossrefPubMedGoogle Scholar
  • 16 Lukas-Croisier C, Lasala C, Nicaud J. et al. Follicle-stimulating hormone increases testicular anti-Mullerian hormone (AMH) production through Sertoli cell proliferation and a nonclassical cyclic adenosine 5′-monophosphate-mediated activation of the AMH Gene. Mol Endocrinol 2003; 17 (04) 550-561
    CrossrefPubMedGoogle Scholar
  • 17 Grumbach MM. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 2005; 90 (05) 3122-3127
    CrossrefPubMedGoogle Scholar
  • 18 Müller J, Skakkebaek NE. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl 1983; 6 (02) 143-156
    CrossrefPubMedGoogle Scholar
  • 19 Nistal M, Abaurrea MA, Paniagua R. Morphological and histometric study on the human Sertoli cell from birth to the onset of puberty. J Anat 1982; 134 (Pt 2): 351-363
    PubMedGoogle Scholar
  • 20 Lee MM, Donahoe PK, Silverman BL. et al. Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 1997; 336 (21) 1480-1486
    CrossrefPubMedGoogle Scholar
  • 21 Boukari K, Meduri G, Brailly-Tabard S. et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J Clin Endocrinol Metab 2009; 94 (05) 1818-1825
    CrossrefPubMedGoogle Scholar
  • 22 Rey R. Endocrine, paracrine and cellular regulation of postnatal anti-Müllerian hormone secretion by Sertoli cells. Trends Endocrinol Metab 1998; 9 (07) 271-276
    CrossrefPubMedGoogle Scholar
  • 23 Rey R, al-Attar L, Louis F. et al. Testicular dysgenesis does not affect expression of anti-Müllerian hormone by Sertoli cells in premeiotic seminiferous tubules. Am J Pathol 1996; 148 (05) 1689-1698
    PubMedGoogle Scholar
  • 24 Al-Attar L, Noël K, Dutertre M. et al. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J Clin Invest 1997; 100 (06) 1335-1343
    CrossrefPubMedGoogle Scholar
  • 25 Rey R, Lordereau-Richard I, Carel JC. et al. Anti-Müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab 1993; 77 (05) 1220-1226
    PubMedGoogle Scholar
  • 26 Young J, Chanson P, Salenave S. et al. Testicular anti-Mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005; 90 (02) 724-728
    CrossrefPubMedGoogle Scholar
  • 27 Teixeira J, Maheswaran S, Donahoe PK. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 2001; 22 (05) 657-674
    PubMedGoogle Scholar
  • 28 Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, Donahoe PK. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. J Pediatr Surg 1993; 28 (03) 439-444
    CrossrefPubMedGoogle Scholar
  • 29 Long WQ, Ranchin V, Pautier P. et al. Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 2000; 85 (02) 540-544
    PubMedGoogle Scholar
  • 30 Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS. Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci U S A 2009; 106 (17) 7203-7208
    CrossrefPubMedGoogle Scholar
  • 31 Cimino I, Casoni F, Liu X. et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 2016; 7 (01) 10055
    CrossrefPubMedGoogle Scholar
  • 32 Josso N, Rey RA, Pask A. Editorial: fetal testicular hormones. Front Endocrinol (Lausanne) 2022; 13: 1090088
    CrossrefPubMedGoogle Scholar
  • 33 Picard JY, Cate RL, Racine C, Josso N. The persistent Müllerian duct syndrome: an update based upon a personal experience of 157 cases. Sex Dev 2017; 11 (03) 109-125
    CrossrefPubMedGoogle Scholar
  • 34 Josso N, Rey RA. What does AMH tell us in pediatric disorders of sex development?. Front Endocrinol (Lausanne) 2020; 11: 619
    CrossrefPubMedGoogle Scholar
  • 35 Virtanen HE, Bjerknes R, Cortes D. et al. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 2007; 96 (05) 611-616
    CrossrefPubMedGoogle Scholar
  • 36 Grinspon RP, Rey RA. Anti-Müllerian hormone and Sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr 2010; 73 (02) 81-92
    CrossrefPubMedGoogle Scholar
  • 37 Albescú JZ, Bergadá C, Cullen M. Male fertility in patients treated for cryptorchidism before puberty. Fertil Steril 1971; 22 (12) 829-833
    CrossrefPubMedGoogle Scholar
  • 38 Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007; 356 (18) 1835-1841
    CrossrefPubMedGoogle Scholar
  • 39 Engeler DS, Hösli PO, John H. et al. Early orchiopexy: prepubertal intratubular germ cell neoplasia and fertility outcome. Urology 2000; 56 (01) 144-148
    CrossrefPubMedGoogle Scholar
  • 40 Thorup J, McLachlan R, Cortes D. et al. What is new in cryptorchidism and hypospadias–a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg 2010; 45 (10) 2074-2086
    CrossrefPubMedGoogle Scholar
  • 41 Matuszczak E, Hermanowicz A, Debek W, Oksiuta M, Dzienis-Koronkiewicz E, Zelazowska-Rutkowska B. Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of life. Endocrine 2012; 41 (02) 334-337
    CrossrefPubMedGoogle Scholar
  • 42 Demircan M, Akinci A, Mutus M. The effects of orchiopexy on serum anti-Müllerian hormone levels in unilateral cryptorchid infants. Pediatr Surg Int 2006; 22 (03) 271-273
    CrossrefPubMedGoogle Scholar
  • 43 Guibourdenche J, Lucidarme N, Chevenne D. et al. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 2003; 211 (1-2): 55-63
    CrossrefPubMedGoogle Scholar
  • 44 Tüttelmann F, Dykstra N, Themmen APN, Visser JA, Nieschlag E, Simoni M. Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertil Steril 2009; 91 (05) 1812-1819
    CrossrefPubMedGoogle Scholar
  • 45 Kumar S, Tomar V, Yadav SS, Priyadarshi S, Vyas N, Agarwal N. Fertility potential in adult hypospadias. J Clin Diagn Res 2016; 10 (08) PC01-PC05
    PubMedGoogle Scholar
  • 46 Asklund C, Jensen TK, Main KM, Sobotka T, Skakkebaek NE, Jørgensen N. Semen quality, reproductive hormones and fertility of men operated for hypospadias. Int J Androl 2010; 33 (01) 80-87
    CrossrefPubMedGoogle Scholar
  • 47 Hero M, Tommiska J, Vaaralahti K. et al. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B. Fertil Steril 2012; 97 (05) 1242-1247
    CrossrefPubMedGoogle Scholar
  • 48 Rey RA, Grinspon RP, Gottlieb S. et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology 2013; 1 (01) 3-16
    CrossrefPubMedGoogle Scholar
  • 49 Coutant R, Biette-Demeneix E, Bouvattier C. et al. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab 2010; 95 (12) 5225-5232
    CrossrefPubMedGoogle Scholar
  • 50 Gravholt CH, Chang S, Wallentin M, Fedder J, Moore P, Skakkebæk A. Klinefelter syndrome: integrating genetics, neuropsychology, and endocrinology. Endocr Rev 2018; 39 (04) 389-423
    CrossrefPubMedGoogle Scholar
  • 51 Bastida MG, Rey RA, Bergadá I. et al. Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome. Clin Endocrinol (Oxf) 2007; 67 (06) 863-870
    CrossrefPubMedGoogle Scholar
  • 52 Lahlou N, Fennoy I, Carel JC, Roger M. Inhibin B and anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol Metab 2004; 89 (04) 1864-1868
    CrossrefPubMedGoogle Scholar
  • 53 Renault L, Labrune E, Giscard d'Estaing S. et al. Delaying testicular sperm extraction in 47,XXY Klinefelter patients does not impair the sperm retrieval rate, and AMH levels are higher when TESE is positive. Hum Reprod 2022; 37 (11) 2518-2531
    CrossrefPubMedGoogle Scholar
  • 54 Benderradji H, Prasivoravong J, Marcelli F. et al. Contribution of serum anti-Müllerian hormone in the management of azoospermia and the prediction of testicular sperm retrieval outcomes: a study of 155 adult men. Basic Clin Androl 2021; 31 (01) 15
    CrossrefPubMedGoogle Scholar
  • 55 Romeo C, Santoro G. Varicocele and infertility: why a prevention?. J Endocrinol Invest 2009; 32 (06) 559-561
    CrossrefPubMedGoogle Scholar
  • 56 Bellastella G, Carotenuto R, Caiazzo F. et al. Varicocele: an endocrinological perspective. Front Reprod Health 2022; 4: 863695
    CrossrefPubMedGoogle Scholar
  • 57 Trigo RV, Bergadá I, Rey R. et al. Altered serum profile of inhibin B, pro-alphaC and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele. Clin Endocrinol (Oxf) 2004; 60 (06) 758-764
    CrossrefPubMedGoogle Scholar
  • 58 Goulis DCh, Mintziori G, Koliakos N. et al. Inhibin B and anti-Müllerian hormone in spermatic vein of subfertile men with varicocele. Reprod Sci 2011; 18 (06) 551-555
    CrossrefPubMedGoogle Scholar
  • 59 Goulis DG, Iliadou PK, Tsametis C. et al. Serum anti-Müllerian hormone levels differentiate control from subfertile men but not men with different causes of subfertility. Gynecol Endocrinol 2008; 24 (03) 158-160
    CrossrefPubMedGoogle Scholar
  • 60 Schwartz CL. ed. Survivors of childhood and adolescent cancer: a multidisciplinary approach. In: Pediatric oncology. 2nd ed.. Berlin: Springer; 2005: 348
    CrossrefGoogle Scholar
  • 61 Leroy C, Cortet-Rudelli C, Desailloud R. [Endocrine consequences in young adult survivors of childhood cancer treatment]. Ann Endocrinol (Paris) 2015; 76 (6, Suppl 1): S29-S38
    PubMedGoogle Scholar
  • 62 Cuny A, Trivin C, Brailly-Tabard S. et al. Inhibin B and anti-Müllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr 2011; 158 (06) 1016-1022.e1
    CrossrefPubMedGoogle Scholar
  • 63 Laporte S, Couto-Silva AC, Trabado S. et al. Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr 2011; 11 (01) 20
    CrossrefPubMedGoogle Scholar
  • 64 Muttukrishna S, Yussoff H, Naidu M. et al. Serum anti-Müllerian hormone and inhibin B in disorders of spermatogenesis. Fertil Steril 2007; 88 (02) 516-518
    CrossrefPubMedGoogle Scholar
  • 65 Xiong Z, Ye Z, Tu J, Meng TQ, Ren N. [Serum anti-Müllerian hormone level for differential diagnosis of obstructive and non-obstructive azoospermia]. Zhonghua Nan Ke Xue 2019; 25 (09) 823-827
    PubMedGoogle Scholar
  • 66 Shu J. Serum anti – Mullerian hormone in azoospermia approach. Farmacia 2023; 71 (02) 280-287
    CrossrefPubMedGoogle Scholar
  • 67 Peng LP, Shao Y, Wang CC. et al. [Correlation of serum anti-Müllerian hormone with semen parameters]. Zhonghua Nan Ke Xue 2017; 23 (06) 531-535
    PubMedGoogle Scholar
  • 68 Aksglaede L, Olesen IA, Carlsen E, Petersen JH, Juul A, Jørgensen N. Serum concentration of anti-Müllerian hormone is not associated with semen quality. Andrology 2018; 6 (02) 286-292
    CrossrefPubMedGoogle Scholar
  • 69 Kucera R, Ulcova-Gallova Z, Windrichova J, Losan P, Topolcan O. Anti-Müllerian hormone in serum and seminal plasma in comparison with other male fertility parameters. Syst Biol Reprod Med 2016; 62 (03) 223-226
    CrossrefPubMedGoogle Scholar
  • 70 El-Halawaty S, Azab H, Said T. et al. Assessment of male serum anti-Mullerian hormone as a marker of spermatogenesis and ICSI outcome. Gynecol Endocrinol 2011; 27 (06) 401-405
    CrossrefPubMedGoogle Scholar
  • 71 Rashad M, Azab M. Assessment of semen parameters and anti-Müllerian hormone level in patients with chronic kidney disease on hemodialysis: a case control study. JOMH 2021; 17 (04) 72-77
    PubMedGoogle Scholar
  • 72 Domain G, Buczkowska J, Kalak P. et al. Serum anti-Müllerian hormone: a potential semen quality biomarker in stud dogs?. Animals (Basel) 2022; 12 (03) 323
    CrossrefPubMedGoogle Scholar
  • 73 Andersen JM, Herning H, Witczak O, Haugen TB. Anti-Müllerian hormone in seminal plasma and serum: association with sperm count and sperm motility. Hum Reprod 2016; 31 (08) 1662-1667
    CrossrefPubMedGoogle Scholar
  • 74 Mostafa T, Amer MK, Abdel-Malak G. et al. Seminal plasma anti-Müllerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE). Asian J Androl 2007; 9 (02) 265-270
    CrossrefPubMedGoogle Scholar
  • 75 Turhan G, Çil N, Kabukçu C, Turan T, Fenkçi İV, Abban Mete G. Relationship of seminal plasma anti-Müllerian hormone concentration with sperm morphology and sperm DNA damage. J Urol Surg 2022; 9 (04) 272-280
    CrossrefPubMedGoogle Scholar
  • 76 Holst BS, Panzani D, Camillo F, Svensson A, Rota A. Anti-Müllerian hormone (AMH) concentrations are maximal at puberty in male donkeys and secretion is redirected from the blood stream to seminal plasma. Anim Reprod Sci 2020; 218: 106484
    CrossrefPubMedGoogle Scholar
  • 77 Fénichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G. Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod 1999; 14 (08) 2020-2024
    CrossrefPubMedGoogle Scholar
  • 78 Siow Y, Fallat ME, Amin FA, Belker AM. Müllerian inhibiting substance improves longevity of motility and viability of fresh and cryopreserved sperm. J Androl 1998; 19 (05) 568-572
    CrossrefPubMedGoogle Scholar
  • 79 Nery SF, Vieira MAF, Dela Cruz C. et al. Seminal plasma concentrations of anti-Müllerian hormone and inhibin B predict motile sperm recovery from cryopreserved semen in asthenozoospermic men: a prospective cohort study. Andrology 2014; 2 (06) 918-923
    CrossrefPubMedGoogle Scholar
  • 80 Dong S, Chen C, Zhang J, Gao Y, Zeng X, Zhang X. Testicular aging, male fertility and beyond. Front Endocrinol (Lausanne) 2022; 13: 1012119
    CrossrefPubMedGoogle Scholar
  • 81 Chong YH, Dennis NA, Connolly MJ. et al. Elderly men have low levels of anti-Müllerian hormone and inhibin B, but with high interpersonal variation: a cross-sectional study of the Sertoli cell hormones in 615 community-dwelling men. PLoS One 2013; 8 (08) e70967
    CrossrefPubMedGoogle Scholar
  • 82 Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Minooee S, Azizi F. Serum variations of anti-Mullerian hormone and total testosterone with aging in healthy adult Iranian men: a population-based study. PLoS One 2017; 12 (07) e0179634
    CrossrefPubMedGoogle Scholar